Mallinckrodt plans to spin off its specialty generics unit to create two independent, publicly traded companies, the drugmaker said in an update May 28.
Pharmacy
The first trial related to the opioid crisis in the U.S. against a drugmaker is set to begin May 28 in Oklahoma.
Teva Pharmaceuticals has agreed to pay $85 million to resolve Oklahoma's claims that the company helped fuel the opioid epidemic with deceptive marketing practices.
The FDA has approved Zolgensma, Novartis' $2.1 million gene therapy for spinal muscular atrophy.
The owner of St. Vrain Pharmacy in Lyons, Colo., pleaded guilty of illegal distribution of narcotics and was sentenced to six months in federal prison, according to CBS Denver.
Advertisement
Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.
Dynavax, a biotech company based in Berkley, Calif., will cut 82 jobs as part of a restructuring plan to prioritize its vaccine business, according to Biospace.
The American Pain Society is considering filing for bankruptcy as opioid-related legal costs continue to grow, according to STAT.
Purdue Pharma must find a new bank to manage cash and bill payments after JPMorgan Chase ended its relationship with the OxyContin maker over the drugmakers alleged role in the opioid crisis, according to CNBC.
Aegerion Pharmaceuticals filed for bankruptcy, the Cambridge, Mass.-based drugmaker said May 21.